Evelo Biosciences, Inc.
EVLO · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $140,342 | $321,170 | $477,303 | $130,049 |
| - Cash | $47,940 | $68,441 | $68,857 | $77,833 |
| + Debt | $51,138 | $56,293 | $40,037 | $19,634 |
| Enterprise Value | $143,540 | $309,022 | $448,483 | $71,850 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$106,345 | -$115,396 | -$89,860 | -$84,421 |
| % Margin | – | – | – | – |
| Net Income | -$114,527 | -$122,176 | -$93,666 | -$85,662 |
| % Margin | – | – | – | – |
| EPS Diluted | -26.28 | -46.18 | -47.45 | -53.49 |
| % Growth | 43.1% | 2.7% | 11.3% | – |
| Operating Cash Flow | -$101,235 | -$96,725 | -$73,063 | -$71,980 |
| Capital Expenditures | -$622 | -$1,519 | -$1,321 | -$3,032 |
| Free Cash Flow | -$101,857 | -$98,244 | -$74,384 | -$75,012 |